Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARE-HF: Atorvastatin for Prevention of Anthracycline-Induced Heart Failure
NCT03186404Phase 2Unknown
- Sponsor
- University Health Network
- Start
- May 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Cardiotoxicity comparing Atorvastatin Arm with Placebo Arm (2 arms). Primary endpoint: Left Ventricular Ejection Fraction. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
heart failure (HF)Cardiotoxicity
Beyond the preview
Go deeper on NCT03186404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186404.